First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington’s disease: A proposal to chemists
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Bioorganic & medicinal chemistry letters - 26(2016), 23, Seite 5712-5718 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Amin, Sk. Abdul [VerfasserIn] |
|---|
| Links: |
|---|
| RVK: |
|---|
| doi: |
10.1016/j.bmcl.2016.10.058 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1989325556 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1989325556 | ||
| 003 | DE-627 | ||
| 005 | 20230715024905.0 | ||
| 007 | tu | ||
| 008 | 170207s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmcl.2016.10.058 |2 doi | |
| 028 | 5 | 2 | |a PQ20170501 |
| 035 | |a (DE-627)OLC1989325556 | ||
| 035 | |a (DE-599)GBVOLC1989325556 | ||
| 035 | |a (PRQ)crossref_primary_10_1016_j_bmcl_2016_10_0580 | ||
| 035 | |a (KEY)0209141020160000026002305712firstmolecularmodelingreportonnovelarylpyrimidinek | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |a 610 |q DE-600 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a VA 2620 |q AVZ |2 rvk | ||
| 100 | 1 | |a Amin, Sk. Abdul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington’s disease: A proposal to chemists |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Adhikari, Nilanjan |4 oth | |
| 700 | 1 | |a Jha, Tarun |4 oth | |
| 700 | 1 | |a Gayen, Shovanlal |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry letters |d Amsterdam [u.a.] : Elsevier, 1991 |g 26(2016), 23, Seite 5712-5718 |w (DE-627)130952400 |w (DE-600)1063195-1 |w (DE-576)025097946 |x 0960-894X |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2016 |g number:23 |g pages:5712-5718 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.bmcl.2016.10.058 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_4305 | ||
| 936 | r | v | |a VA 2620 |
| 951 | |a AR | ||
| 952 | |d 26 |j 2016 |e 23 |h 5712-5718 | ||